Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemiaJunya Kuroda, T Maekawa|Cell Death and Differentiation|2007Cited by 65
p53‐independent anti‐tumor effects of the nitrogen‐containing bisphosphonate zoledronic acidJunya Kuroda, Taira Maekawa|Cancer Science|2004Cited by 37
BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic ApproachTaku Tsukamoto, Junya Kuroda|Cancer Genomics & Proteomics|2019Cited by 18
Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphomaYayoi Matsumura‐Kimoto, Junya Kuroda|Cancer Medicine|2020Cited by 10
miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphomaYuka Kawaji‐Kanayama, Junya Kuroda|Cancer Science|2023Cited by 7